Share of the population living with HIV receiving antiretroviral therapy in Indonesia

Indonesia: Share of the population living with HIV receiving antiretroviral therapy was 40.7% in 2024. ◆ Volatile

Latest (2024)
40.7%
Change on year
up 30.5%
World rank
138th
of 149 countries
All-time high
40.7%
in 2024
All-time low
0.0%
in 1990
Years of data
35
1990–2024

Share of the population living with HIV receiving antiretroviral therapy in Indonesia, 1990–2024

0102030401990200720241990: 0 %1991: 0 %1992: 0 %1993: 0 %1994: 0 %1995: 0 %1996: 0 %1997: 0 %1998: 0 %1999: 0.008 %2000: 0.009 %2001: 0.011 %2002: 0.011 %2003: 0.011 %2004: 0.01 %2005: 0.258 %2006: 1.8 %2007: 2.4 %2008: 3 %2009: 4.2 %2010: 4.8 %2011: 5.5 %2012: 6.5 %2013: 7.6 %2014: 9.8 %2015: 11.9 %2016: 14.3 %2017: 16.5 %2018: 19.3 %2019: 22.4 %2020: 24.9 %2021: 26.7 %2022: 28.9 %2023: 31.2 %2024: 40.7 %

Source: Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data. Measured in %.

Analysis

The most recent figure for share of the population living with hiv receiving antiretroviral therapy in Indonesia is 40.7%, measured in 2024. That is the highest value across all 35 years on record.

The figure is up 30.5% on the previous year and up 317.4% over ten years.

Over the whole period, share of the population living with hiv receiving antiretroviral therapy in Indonesia peaked at 40.7% in 2024 and was at its lowest, 0.0%, in 1990.

Indonesia ranks 138th of 149 countries on this measure, in the bottom quarter.

The series is highly variable year to year, so single readings are best treated with caution.

Share of the population living with HIV receiving antiretroviral therapy in Indonesia, year by year

Annual values for Share of the population living with HIV receiving antiretroviral therapy in Indonesia, 1990 to 2024.
Year % Change
1990 0.0% —
1991 0.0% —
1992 0.0% —
1993 0.0% —
1994 0.0% —
1995 0.0% —
1996 0.0% —
1997 0.0% —
1998 0.0% —
1999 0.0% —
2000 0.0% +22.6%
2001 0.0% +14.2%
2002 0.0% -2.4%
2003 0.0% -0.3%
2004 0.0% -1.3%
2005 0.3% +2378.3%
2006 1.8% +587.9%
2007 2.4% +33.5%
2008 3.0% +28.9%
2009 4.2% +36.3%
2010 4.8% +15.1%
2011 5.5% +15.5%
2012 6.5% +18.5%
2013 7.6% +15.9%
2014 9.8% +28.5%
2015 11.9% +22.2%
2016 14.3% +20.4%
2017 16.5% +15.1%
2018 19.3% +16.9%
2019 22.4% +16.3%
2020 24.9% +11.2%
2021 26.7% +6.9%
2022 28.9% +8.3%
2023 31.2% +7.9%
2024 40.7% +30.5%

Indonesia compared with similar countries

  • Indonesia's 40.7% is below the median for upper middle income countries, which is 65.5%, 62% of the median. (43 countries reporting)
  • Indonesia's 40.7% is below the median for East Asia & Pacific, which is 64.2%, 63% of the median. (15 countries reporting)

Biggest year-on-year movements

Years where Share of the population living with HIV receiving antiretroviral therapy in Indonesia changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2005 +2378.3% 0.0% 0.3%
2006 +587.9% 0.3% 1.8%

Averages by decade

DecadeAverage LowestHighest Years
1990s 0.0% 0.0% 0.0% 10
2000s 1.2% 0.0% 4.2% 10
2010s 11.9% 4.8% 22.4% 10
2020s 30.5% 24.9% 40.7% 5

Countries ranked near Indonesia

  1. 135 Gambia 44.3% compare
  2. 136 Saint Lucia 42.9% compare
  3. 137 Bangladesh 41.4% compare
  4. 139 Mongolia 40.6% compare
  5. 140 Philippines 40.4% compare
  6. 141 Congo 33.7% compare

See the full ranking of 149 places →

More reference data data for Indonesia

All data for Indonesia →

Frequently asked questions

What is share of the population living with hiv receiving antiretroviral therapy in Indonesia?
Share of the population living with hiv receiving antiretroviral therapy in Indonesia was 40.7% in 2024, according to Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data.
What is the highest share of the population living with hiv receiving antiretroviral therapy recorded in Indonesia?
The highest recorded value was 40.7% in 2024.
What is the lowest share of the population living with hiv receiving antiretroviral therapy recorded in Indonesia?
The lowest recorded value was 0.0% in 1990.
How does Indonesia rank for share of the population living with hiv receiving antiretroviral therapy?
Indonesia ranks 138th out of 149 countries with data for 2024.
Is share of the population living with hiv receiving antiretroviral therapy rising or falling in Indonesia?
Over the last ten years it is up 317.4%. The long-run trend across the full record is volatile.
Where does this Indonesia data come from?
The figures come from Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as part of Share of the population living with HIV receiving antiretroviral therapy. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 35 observations, free to reuse under CC BY 4.0 (Our World in Data).

Share, cite or embed this page

Cite this page

Share of the population living with HIV receiving antiretroviral therapy in Indonesia. Statizoid, drawing on Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data. Retrieved 29 September 2026, from https://reference.statizoid.com/stat/gap-to-reaching-the-target-of-art/indonesia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://reference.statizoid.com/stat/gap-to-reaching-the-target-of-art/indonesia/">Share of the population living with HIV receiving antiretroviral therapy in Indonesia</a> — Statizoid

About this data

Indicator
Share of the population living with HIV receiving antiretroviral therapy
Unit
%
Source
Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
149 places, 5,062 data points, 1990–2024
Last refreshed

Percentage of individuals diagnosed with HIV who are currently receiving antiretroviral therapy. This is the central estimate.